Regulatory Requirements of Biosimilars: Drug Development in Ophthalmology, Part 1. Rowe-Rendleman CL. J Ocul Pharmacol Ther 2024 Nov 4. doi: 10.1089/jop.2024.0151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rowe-Rendleman CL. Regulatory Requirements of Biosimilars: Drug Development in Ophthalmology, Part 1. J Ocul Pharmacol Ther 2024 Nov 4. doi: 10.1089/jop.2024.0151.
PMID: 39492726